Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

NAPLEX > Schizophrenia/Psychosis > Flashcards

Schizophrenia/Psychosis Flashcards

1
Q

Positive symptoms:

A
  • Hallucinations: sensing something that is not present, such as imaginary voices (ex. auditory)
  • Delusions: ex. paranoia
  • Disorganized thinking/behavior: inability to focus attention and communicate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Negative symptoms:

A
  • flat affect
  • anhedonia
  • avolition (lack of motivation)
  • alogia (decreased thought and speech)
  • withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Increased dopamine can trigger hallucinations or delusions. Up to 50% of patients with PD will…

A

experience hallucinations or delusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Antipsychotics primarily block…

A

dopamine receptors. Newer ones also block serotonin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medications/drugs that can cause psychotic symptoms:

A
  • anticholinergics (centrally-acting, high doses)
  • dextrometorphan
  • dopamine or dopamine agonists (e.g Requip, Mirapex, Sinemet)
  • interferons
  • stimulants
  • systemic steroids (typically with lack of sleep- ICU psychosis)
  • Illicit substances (bath salts, cannabis, cocaine, LSD, meth, PCP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

First-gen antipsychotics (FGAs) have a high incidence of EPS…

A

including painful dystonias (muscle contractions), dyskinesias (abnormal movements), tardive dyskinesias (repetitive, involuntary movements, such as grimacing and eye blinking), and akathisia (restlessness, inability to remain still)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Tardive dyskinesia (TD) can be irreversible; the drug causing the TD should be…

A

d/c’ed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Olanzapine and benzodiazepines should not be given together…

A

due to risk of excessive sedation and breathing difficulty

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

IM antipsychotics are often mixed with other drugs (in “cocktails”), such as…

A

benzos for anxiolytic/sedative effects, and anticholinergics to reduce dystonias (eg. the “Haldol cocktail” contains haloperidol, lorazepam, and diphenhydramine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BBW: Elderly patients with dementia-related psychosis

A

increased risk of death from antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Low potency FGA: thioridazine

A

300-800 mg/day, divided. QT prolongation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Low potency FGA: chlorpromazine

A

300-1000 mg/day, divided.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mid potency: loxapine (Loxitane, Adasuve)

A

30-100 mg/day, divided. Inhalation powder for acute agitation. REMS: bronchospasm. S/s: bad, bitter, or metallic taste in mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mid potency: perphenazine

A

8-64 mg/day, divided.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

High potency: haloperidol (Haldol, Haldol decanoate). Oral, IV, decanoate IM. Class: butyrophenone. Also used for Tourette’s syndrome.

A
  • oral (tablet, solution): start 0.5-2 mg BID-TID (up to 30 mg/day)
  • IV: usually 5-10 mg.
  • Decanoate (monthly): IM only;
  • for conversion from IM to PO, use 10-20x the PO dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

High potency: fluphenazine (tablet, elixir, injectable, IM,)

A

6-12 mg/day, divided. Decanoate: (Q 2 weeks); IM only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

High potency: thiothixene

A

15-60 mg/day; divided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

High potency: trifluoperazine

A

15-50 mg/day; divided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lower potency FGAs have…

A

less sedation, more EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Higher potency FGAs have…

A

less sedation, more EPS

21
Q

Second-generation antipsychotics (SGAs) block…

A

dopamine (D2) and serotonin (5-HT2A) receptor

22
Q

Unique MOAs: D2 and HT1A2 partial agonists are…

A

Aripiprazole, brexpiprazole, cariprazine

23
Q

aripiprazole (Abilify, Abilify Maintena, Aristada injection) Tablet, ODT, IM suspension

A
  • 10-30 mg PO QAM
  • Abilify Maintena- IM suspension (give monthly)
  • Aristada- IM suspension, give Q 4-8 weeks
  • SEs: akathisia, headache, anxiety, sedating or activating
  • Lower risk of weight gain, some QT prolongation, EPS (in children)
24
Q

clozapine (Clozaril, FazaClo ODT, Versacloz suspension)

A

Very effective and has decreased risk of EPS/TD, but only used 3rd line due to severe side effect potential.
BBW: significant risk of potentially life-threatening neutropenia/agranulocytosis (REMS program)

25
Q

clozapine s/e

A

S/Es: agranulocytosis, seizures (dose-related), constipation, somnolence, metabolic syndrome, sialorrhea (hypersalivation), hypotension
Monitoring: prescribers and pharmacies must be certified to dispense. To start tx, baseline ANC must be ≥ 1,500/mm3. Check ANC weekly x 6 months, then every 2 weeks x 6 months, then monthly. Stop therapy if ANC <1000/mm3.

26
Q

lurasidone (Latuda)

A

40-160 mg/day, divided. Counsel to take with food (≥ 350 kcal). CIs: use with strong CYP450 3A4 inducers/inhibitors. Almost weight, lipid, and BG neutral.

27
Q

olanzapine (Zyprexa, Zyprexa Zydis ODT, Zyprexa Relprevv injection)

A
  • 10-20 mg QHS (counsel to take at night).

- IM injection (acute agitation)

28
Q

olanzapine + fluoxetine (Symbyax)

A

for treatment-resistant depression

29
Q

Zyprexa Relprevv injection. **Must be given in a registered healthcare facility, and patients must be monitored for 3 hours post-injection (REMS program)

A
  • IM gluteal injection
  • suspension lasts 2-4 weeks (restricted use).
  • BBW: sedation (including coma), and delirium (agitation, anxiety, confusion, disorientation) have been observed following injection
30
Q

paliperidone (Invega, Invega Sustenna, Invega Trinza). Active metabolite of risperidone (similar SEs)

A
  • PO: 3-12 mg daily
  • Invega Sustenna (IM injection, give monthly)
  • Invega Trinza (IM injection, give Q 3 months; start only after receiving Invega Sustenna x 4 months)
  • SEs: increased prolactin (sexual dysfunction, galactorrhea, irregular periods)
  • EPS (especially at higher doses)
  • tachycardia, QT prolongation
  • metabolic syndrome (weight gain, BG, increased lipids)
31
Q

Invega can leave a ghost tablet…

A

in the stool (OROS delivery). Counsel.

32
Q

quetiapine (Seroquel, Seroquel XR)

A

400-800 mg/day; divided BID or XR QHS

  • Take XR at night, without food or with a light meal (≤300 kcal)
  • Lowest EPS risk- often used for psychosis in Parkinson’s
  • S/Es: somnolence, metabolic syndrome, orthostasis, possible ocular effects (cataracts)
33
Q

risperidone (Risperdal, Risperdal Consta, Perseris). Active metabolite is paliperidone.

A
  • Also approved for irritability associated with autism
  • 4-16 mg/day, divided
  • Risperdal Consta: IM injection; give Q 2 weeks; 25-50 mg
  • Perseris: SC injection, give monthly
34
Q

ziprasidone (Geodon)

A
  • 40-160 mg/day, divided BID
  • Take with food (counsel)
  • CIs: QT prolongation; do not use with QT risk
35
Q

Acute injection: Geodon IM

A
  • 10 mg Q2 hrs or 20 mg Q4hrs

- Max: 40 mg/day IM

36
Q

asenapine (Saphris, Secuado). Saphris (SL tablet); Secuado (patch)

A
  • 10-20 mg/day, divided BID.
  • No food/drink for 10 min after dose (counsel)
  • Secuado patch: apply daily
  • CIs: severe liver impairment
  • SEs: somnolence, tongue numbness (SL tablet), EPS (5 % more than placebo), QT prolongation
37
Q

brexpiprazole (Rexulti)

A

2-4 mg daily

38
Q

cariprazine (Vraylar)

A

1.5-6 mg daily

39
Q

lloperidone (Fanapt)

A

12-24 mg/day, divided. Titrate slowly due to orthostasis/dizziness.

40
Q

lumateperone (Caplyta)

A

42 mg daily

41
Q

Cardiac risk/QT risk (d/c with QT>500 msec)

A

do not choose ziprasidone, haloperidol, thioridazine, chlorpromazine

42
Q

History of movement disorder (ex. Parkinson’s disease)

A
  • Do not choose FGAs, risperidone, paliperidone

- Quetiapine is preferred.

43
Q

Overweight/metabolic risk (eg. increased TG)

A
  • Do not choose clozapine, olanzapine, quetiapine. - Lower risk with aripiprazole, ziprasidone, lurasidone, and asenapine.
44
Q

pimavenserin (Nuplazid): approved for psychosis with Parkinson disease (does not affect dopamine)

A
  • inverse agonist and antagonist at serotonin 5-HT2A receptors
  • 34 mg PO daily (two 17 mg tablets)
    Warnings: not approved for dementia-related psychosis. QT prolongation.
  • SEs: peripheral edema, confusion
45
Q

Smoking can reduce plasma levels of…

A

olanzapine and clozapine

46
Q

Risperidone oral solution

A

given directly from the calibrated pipette, or mixed with water, coffee, OJ and low-fat milk; it cannot be mixed with cola or tea.

47
Q

velbenazine (Ingrezza). First med approved for the treatment of TD.

A
  • MOA: Reversibly inhibits vesicular monoamine transporter 2 (VMAT2)
  • Dosing: Start 40 mg PO daily, increase in 1 week to 80 mg PO daily
  • Moderate-severe liver impairment: adjustment required. CYP2D6 PM: consider dose reduction.
  • Warnings: somnolence, QT prolongation
48
Q

deutetrabenazine (Austedo). Another VMAT2 inhibitor approved for TD.

A
  • Also, approved for chorea associated with Huntington’s disease
  • Dosing: Start 6 mg PO BID, increased weekly based on response (max 48 mg/day)
  • Concurrent strong CYP2D6 inhibitors or PM (max dose 36 mg/day)
  • CIs: liver impairment, administration with tetrabenazine or velbenazine, administration with an MAO inhibitor (within 14 days)
  • Warnings: somnolence, QT prolongation
49
Q

Neuroleptic Malignant Syndrome Tx (signs include hyperthermia, extreme muscle rigidity, mental status changes) Labs: increased CPK and WBCs

A
  • Taper off antipsychotic quickly and consider another choice (quetiapine or clozapine)
  • Provide supportive care
  • Cool the patient down: cooling bed, antipyretics, cooled IV fluids
  • Muscle relaxation with benzos or dantrolene (Ryanodex, Dantrium, Revonto)

NAPLEX (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions